Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
TEANECK, N.J., March 30, 2016 -- Phibro Animal Health Corporation (NASDAQ:PAHC) will host a webcast and conference call to review third quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on Monday, May 9, 2016.
Details for the webcast and conference call:
| Date: | Tuesday, May 10, 2016 | |||
| Time: | 9:00 AM Eastern Time | |||
| Location: | http://investors.pahc.com | |||
| U.S. Toll-Free: | +1 (877) 853-5634 | |||
| International Toll: | +1 (315) 625-6893 | |||
| Conference ID: | 52883099 | |||
NOTE: In order to join this conference call, all participants will be required to provide the Conference ID number.
Archive: A replay of the webcast and conference call will be available on Phibro’s website.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company reported net sales of $749 million for the fiscal year ended June 30, 2015. For further information, please visit www.pahc.com.
Our filings with the Securities and Exchange Commission are available online at www.sec.gov, www.pahc.com or on request from the company.
Contact: Richard Johnson Phibro Animal Health Corporation Chief Financial Officer +1-201-329-7300 [email protected]
